Others
- Actin(12)
- Adenylate cyclase(27)
- AhR(15)
- Aldose reductase(24)
- Arginase(14)
- AT Receptors(1)
- Autotaxin(4)
- ATP citrate lyase (10)
- BCRP(14)
- Caged Compounds(3)
- ROR/RAR/RXR(95)
- Calmodulin protein kinase II(1)
- CaM kinase II(10)
- Carbonic Anhydrase(54)
- Cell Penetrating Peptide(2)
- Ceramidases(4)
- CERK(1)
- Collagen proline hydroxylase(2)
- COT/TpI2(2)
- COMT(12)
- CPA(1)
- CPG2(1)
- Cytokine(4)
- dCTP Pyrophosphatase(1)
- DHODH(1)
- Diacylglycerol Kinase(1)
- DNA Stain(31)
- eIF2a(2)
- Endopeptidase(3)
- Enzyme Substrates / Activators(70)
- ES-FLI1/RHA(2)
- Farnesyl Diphosphate Synthase(1)
- FBPase(4)
- FLAP(12)
- Fluorescent Probes(344)
- GLI(3)
- Glycoprotein(5)
- Saccharides and Glycosides(13)
- Glyoxalase I(1)
- GSNOR(2)
- GSTP1-1(1)
- Guanylate Cyclase (29)
- Guanylyl Cyclase(7)
- Gutathione S-transferase(13)
- Heme oxygenase(8)
- Hexokinase(4)
- Hydroxylases(10)
- IL Receptor(1)
- Imidazoline Receptors(18)
- IMPDH(1)
- Inositol Phosphatases(4)
- Lp-PLA2(1)
- LpxC(1)
- Matrix Metalloprotease(1)
- MDR multidrug resistance(47)
- Menin-MLL(5)
- MGMT(2)
- Mineralocorticoid Receptor(20)
- Miscellaneous Compounds(9)
- MyD88(7)
- Myosin(24)
- NAE(2)
- NADPH Oxidase(14)
- Nampt(23)
- Natriuretic Peptide Receptors(4)
- Nitric Oxide(85)
- Nuclear Receptors(13)
- Oxygenases/Oxidases(5)
- PDHK(10)
- PGC-1α(2)
- Pregnane X Receptors(2)
- Reductases(7)
- Renin(12)
- Retinoid X Receptors(11)
- Squalene epoxidase(5)
- SGK(13)
- sFRP-1(1)
- SPHK(19)
- Synthases/Synthetases(12)
- Tachykinin(6)
- Thrombopoietin Receptor(7)
- Thymidine phosphorylase(4)
- Transcription Factors(117)
- Transketolase(4)
- β(1,3)-D-Glucan Synthase(2)
- β-Lactamase(3)
- XAO(4)
- Others(2512)
- BMI-1(1)
- Hydrogen Peroxide
- Ascorbic Acid
- SOD(3)
- Homodimerizers(2)
- Renal Diseases(9)
- PAF-AH(1)
- FAS(26)
- calmodulin(3)
- Protein synthesis(5)
- Epac(1)
- MAGL(20)
- exocytosis(1)
- peroxiredoxins(1)
- Glucosidase(47)
- Estrogen Receptor/ERR(171)
- Progesterone Receptor(35)
- Cyclase(6)
- Environmental Toxicology(265)
- Glycerolipid Lipases(15)
- Tec(3)
- Lipases(26)
- Multidrug-Resistance Proteins(8)
- Negative Controls(9)
- Nucleic Acid Turnover/Signaling(73)
- Organ- & System-Specific Toxicity(163)
- Pesticides(119)
- Pharmaceutical Impurities(37)
- Sulfotransferases(4)
- Toxicology(160)
- UDP Glucuronosyltransferases(47)
- Xenobiotic Sensing(27)
- Inhibitory Antibodies(176)
- Amino Acid Derivatives(3)
Others 相关产品(1696)
- GC33760ETC-1002 (ESP-55016)CAS: 738606-46-7纯度: >98.00%
ETC-1002 (ESP-55016) 是一种新型的每日一次口服降脂药物,可抑制腺苷三磷酸柠檬酸裂解酶(ACL),一种胆固醇合成途径中的酶,并导致低密度脂蛋白胆固醇(LDL)受体的上调,半衰期在15到24小时之间。
- GC40138Pro-Adrenomedullin (45-92) (human) (trifluoroacetate salt)纯度: >95.00%
A peptide derived from preproadrenomedullin
- GC40203Cholesterol-d6CAS: 60816-17-3纯度: >99.00%
An internal standard for the quantification of cholesterol
- GC40228Fluvastatin-d6 (sodium salt)纯度: >95.00%
An internal standard for the quantification of fluvastatin
- GC404122-Monostearin (2-Stearoyl-rac-glycerol)CAS: 621-61-4纯度: >95.00%
2-Monostearin (2-Stearoyl-rac-glycerol)是一种在sn-2位含有硬脂酸的单酰基甘油酯。
- GC40434(±)16-HETECAS: 128914-46-5纯度: >98.00%
A potent inhibitor of proximal tubule ATPase activity
- GC40435(±)17-HETECAS: 128914-47-6纯度: >98.00%
A potent inhibitor of proximal tubule ATPase activity
- GC40466(±)11(12)-EETCAS: 87173-81-7纯度: >95.00%
A racemic version of a CYP450 metabolite of arachidonic acid
- GC40967rac-7-methoxy PropranololCAS: 76275-53-1纯度: >95.00%
An intermediate for the preparation of rac-7-hydroxy propranolol
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC33760 | ETC-1002 (ESP-55016) | 738606-46-7 | >98.00% | |
ETC-1002 (ESP-55016) 是一种新型的每日一次口服降脂药物,可抑制腺苷三磷酸柠檬酸裂解酶(ACL),一种胆固醇合成途径中的酶,并导致低密度脂蛋白胆固醇(LDL)受体的上调,半衰期在15到24小时之间。 | ||||
| GC39318 | DSHS00884 | 675104-49-1 | >98.00% | |
DSHS00884 是有效的人乳头瘤病毒 E6 抑制剂,IC50 为 10 μM。 | ||||
| GC40138 | Pro-Adrenomedullin (45-92) (human) (trifluoroacetate salt) | - | >95.00% | |
A peptide derived from preproadrenomedullin | ||||
| GC40156 | PAR4 (1-6) (mouse) (trifluoroacetate salt) | - | >95.00% | |
A peptide agonist of PAR4 | ||||
| GC40203 | Cholesterol-d6 | 60816-17-3 | >99.00% | |
An internal standard for the quantification of cholesterol | ||||
| GC40228 | Fluvastatin-d6 (sodium salt) | - | >95.00% | |
An internal standard for the quantification of fluvastatin | ||||
| GC40340 | Prostaglandin A1 methyl ester | 26771-94-8 | - | |
Lipophilic analog of PGA 1 | ||||
| GC40412 | 2-Monostearin (2-Stearoyl-rac-glycerol) | 621-61-4 | >95.00% | |
2-Monostearin (2-Stearoyl-rac-glycerol)是一种在sn-2位含有硬脂酸的单酰基甘油酯。 | ||||
| GC40434 | (±)16-HETE | 128914-46-5 | >98.00% | |
A potent inhibitor of proximal tubule ATPase activity | ||||
| GC40435 | (±)17-HETE | 128914-47-6 | >98.00% | |
A potent inhibitor of proximal tubule ATPase activity | ||||
| GC40436 | (±)18-HETE | 133268-58-3 | >97.00% | |
A vasodilator of renal arterioles | ||||
| GC40440 | (±)8(9)-EET | - | >98.00% | |
A racemic version of a CYP450 metabolite of arachidonic acid | ||||
| GC40453 | 16(R)-HETE | 183509-22-0 | >95.00% | |
A potent vasodilator | ||||
| GC40454 | 16(S)-HETE | 183509-23-1 | >98.00% | |
A potent inhibitor of proximal tubule ATPase activity | ||||
| GC40456 | 17(S)-HETE | 183509-25-3 | >98.00% | |
A potent inhibitor of proximal tubule ATPase activity | ||||
| GC40458 | 19(S)-HETE | 115461-40-0 | >98.00% | |
Potent vasodilator of renal preglomerular vessels | ||||
| GC40466 | (±)11(12)-EET | 87173-81-7 | >95.00% | |
A racemic version of a CYP450 metabolite of arachidonic acid | ||||
| GC40503 | 2-HOBA | 932-30-9 | >95.00% | |
An isoketal scavenger | ||||
| GC40539 | (±)12(13)-EpOME | - | >98.00% | |
The 12,13-cis epoxide form of linoleic acid | ||||
| GC40624 | MMP-3 Inhibitor VIII | 208663-26-7 | >95.00% | |
A selective inhibitor of MMP-3 | ||||
| GC40801 | (±)9(10)-DiHOME | 263399-34-4 | >98.00% | |
A diol form of (±)9(10)-EpOME | ||||
| GC40802 | (±)12(13)-DiHOME | 263399-35-5 | >98.00% | |
A diol form of (±)12,13-EpOME | ||||
| GC40914 | Pentosidine | 124505-87-9 | >98.00% | |
An advanced glycation end product | ||||
| GC40967 | rac-7-methoxy Propranolol | 76275-53-1 | >95.00% | |
An intermediate for the preparation of rac-7-hydroxy propranolol | ||||
